Open access peer-reviewed chapter

Leishmaniasis Epidemiology and Psychosocial Aspect

Written By

Ghulam Rahim Awab

Submitted: 28 November 2022 Reviewed: 16 February 2023 Published: 22 March 2023

DOI: 10.5772/intechopen.110568

From the Edited Volume

Leishmania Parasites - Epidemiology, Immunopathology and Hosts

Edited by Fernando Almeida-Souza, Flávia de Oliveira Cardoso, Ana Lucia Abreu-Silva and Kátia da Silva Calabrese

Chapter metrics overview

119 Chapter Downloads

View Full Metrics

Abstract

Leishmaniasis is a neglected tropical and the most important vector-borne disease caused by protozoan parasites of the genus Leishmania, transmitted by female sand-fly vector to the vertebrate host including human, highly correlated with poverty, malnutrition, climate and environmental factors such as crowded living conditions and poor sanitation that affect health, wellbeing, and livelihoods of millions of people around the world. Transmission is complex due to relationships between reservoir hosts, parasites, sand fly vectors, and socio-environmental risk factors. There are various clinical manifestations, ranging from spontaneously healing cutaneous lesions to potentially fatal visceral leishmaniasis caused by different Leishmania species. The psychological long-term manifestations leading to stigmatization, social exclusion, discrimination, and psychosocial impacts, advocating the importance of the One Health approach to combat these diseases effectively.

Keywords

  • leishmaniasis
  • neglected tropical diseases
  • vector-borne disease
  • epidemiology
  • sand fly
  • parasite

1. Introduction

Epidemiology of Leishmaniasis is the study of the characteristics of the parasite and sand-fly species, ecological characteristics of the transmission sites, current and past exposure of the human population to the parasite, human behavior, geographical distribution, and impacts on human populations [1]. Leishmaniasis is a multifactorial anthropo-zoonotic protozoal disease, responsible for various syndromes in humans, by way of anthroponotic and/or zoonotic transmission. The interactions among all of the agent, vector, climatic, environmental, and socioeconomic factors influence the risk of leishmaniasis [2]. Infection and transmission are initiated by inoculating of the causative agent (free promastigotes of Leishmania) by vector (female sand flies of the genus Phlebotomus and Lutzomyia) bite in vertebrate hosts [1]. The vertebrate hosts are attacked by female sand flies for blood meals necessary for eggs development cycle.

It is a global public health threat, a neglected grave tropical disease that portends possible poor prognosis and fatal consequences due to broad range of clinical manifestations observed worldwide with numerous endemic zones in various continents and cases are raising due to urbanization, deforestation [1, 3].

Leishmaniasis epidemiology has a major role in clarifying the etiology of particular Leishmania various species and variants as the cause of specific diseases, in improving our understanding of the overall characteristics of specific vectors, in determining factors affecting host susceptibility and immunity, in unraveling modes of transmission, in clarifying the interaction of parasite with environmental determinants of disease, in determining the safety, efficacy, and utility of preventive and curative weapons (personal protection, vaccines, drugs) especially in alerting and directing disease prevention and control actions [4]. Information on morbidity burden and biopsychosocial properties rates contributes directly to the establishment of priorities for prevention and control programs, whether this involves insecticide, drug and vaccine development and delivery, environmental and hygienic improvements, enhancement of socio-economic and nutritional status, personal or community behavior, agricultural and constructional processing enhancements, reservoir host and vector control, and international cooperation and communication.

Advertisement

2. Problem statement

Leishmaniasis is among the top three vector-borne diseases of parasite origin along with malaria and filariasis that impacts significantly on the health, wellbeing, and livelihoods of affected communities. It is also the third most common infectious disease in terms of morbidity, after tuberculosis and malaria with great diversity of parasite species, reservoirs, and vectors that play role in transmission [5]. The disease is considered as an endemic tropical and subtropical zoonotic health threat with outbreak and mortality potential occurs primarily in countries with (sub) tropical climates, disproportionally affecting individuals living with poverty, poor sanitation, malnutrition, restricted healthcare access, displacement, poor housing, weak immunity, and lack of financial resources. Existence in non-endemic areas linked to globalization, urbanization and environmental changes, migration, tourism and other international types of population movements [1]. Different species might cause different clinical features, and the severity differs from spontaneously healing lesions to life-threatening visceral disease that might be ended with more than 90% deaths if not promptly treated particularly in people living with HIV/AIDS [6]. The cutaneous leishmaniasis (CL) is the predominant clinical manifestation with skin lesions or ulcers, on the face, head, arms and legs and other exposed to sand-fly biting parts of the body [7, 8], leaving life-long scars and serious disability, disfiguration and stigma “horrific social discrimination” and cause significant maternal morbidity, and even fetal mortality during pregnancy [3, 9]. Although the disease is not lethal, the disfigurement and social stigmatization may cause or precipitate psychological disorders, restriction of social participation, reduction of health-related quality of life of affected individuals. Thus CL not only affects the physical well-being of the individual but also significantly alters their psychological, social, and economic well-being [10]. The overall leishmaniasis outcomes are determined by the inter-relationship between the individualities of the parasite, the bio-environmental aspects of the vector, and the immune response of host [1].

Advertisement

3. Problem magnitude

Globally, leishmaniasis is among the top ten neglected tropical health burden, endemically existing in people of every continent except Australia and Antarctica. Currently, 98 countries are endemic for leishmaniasis in the tropics, subtropics, and Southern Europe. More than 350 million individuals are at risk, 12 to 15 million infected, and 1.5 to 2 million new cases occur annually with 20,000–30,000 deaths [11, 12]. The endemic regions include Mediterranean Basin, Africa, Central and South America and Asia. As per WHO 2012 report, predictably, 59 countries are endemic for visceral lieshmaniasis, although cases fall excessively on seven of these as 90% of these cases happened in INDIA, South Sudan, Brazil, Ethiopia, Kenya, Sudan, Somalia and among 95% of CL cases occurred in the Americas, Middle East and Central Asia, approximately 70% reported in Syria, Brazil, Algeria, Colombia, Afghanistan, Iran, Ethiopia, Sudan, and Costa Rica [13].

Presently, over 85% of new CL cases occurred in 10 countries, namely Afghanistan, Algeria, Brazil, Colombia, Iraq, Libya, Pakistan, Peru, the Syrian Arab Republic, and Tunisia. Likewise, 10 countries: Brazil, China, Ethiopia, Eritrea, India, Kenya, Somalia, South Sudan, Sudan, and Yemen were accountable for more than 90% of new VL cases reported to WHO [11].

Advertisement

4. Epidemiological determinants

It is known that different species of Leishmania can cause in many mammalian hosts various clinical manifestations, and the severity varies from spontaneously healing lesions to life-threatening visceral disease. The outcome is determined by the inter-relationship between the characteristics of the parasite, the biology and habitat of the vector, and the behavior and immune response of host (Table 1) [1].

AgentVectorReservoir/HostGeographical location
Old World
Labrus donovaniP. Argentipes, P. orientalis, P. martini, P. alexandriHumans (anthroponosis)North-East India, Bangladesh, Nepal, Sudan, Kenya, Horn of Africa, China
L. infantumP. perniciosus, P. perfiliewi, P. chinensis, etc.Dogs, cats, foxes, jackalsMediterranean, Sudan, West Africa, Middle East, China, Central Asia
L. majorP. papatasi, Polypauropus duboscqiGerbils (e.g. Rhombomys, Meriones), Rodents, Human anthroponosisSemideserts in North Africa and Middle East, North India, Pakistan, Central Asia, Sub-Saharan Savannah, Sudan
L. tropicaParalongicollum sergenti,Humans, dogsMediterranean Basin, Central Asia, North Africa, Middle East, Iran, Afghanistan
L. aethiopicaP. longipes, P. pediferHyraxes (Procavia, Heterohyrax), RodentsHighlands of Kenya, Ethiopia, Uganda
New World
L. infantumLu. longipalpis, Lu. evansiDogs, foxes, opossums (Didelphis)Most of Central and South America, especially Brazil
L. mexicanaLu. OlmecaForest rodents (especially Ototylomys)Central and Northern South America
L.amazonensisLu. FlaviscutellataForest rodents (especially Proechimys, Oryzomys)Tropical forests of South America
L. brasiliensisLu. wellcomei, Lu. whitmani, etcRodents, opossums, dogs, and equinesTropical forests & cultivated land throughout South & Central America
L. guyanensisLu. UmbratilisSloths (Choleopus), arboreal anteaters (Tamandua)Northern South America
L. panamensisLu. trapidoi, etc.Sloths (Choleopus)Central America, Ecuador, Colombia
L. peruvianaLu. verrucarum, Lu. PeruensisDogs, rodents, opossumsWest Andes of Peru

Table 1.

Disease types and transmission cycles of leishmaniasis worldwide [14].

Abbreviations P = Phlebotomus, Lu., Lutzomyia.

4.1 Agent

Leishmaniasis human disease is caused by more than 20 pathogenic species of Leishmania parasites transmitted from host to host by a tiny insect. Leishmania parasites are categorized into either old world (The Eastern Hemisphere) or new world (The Western Hemisphere) species, most notably the old world species: L. major, L. tropica, L. aethiopica, and the new world species: L. amazonesis, L. braziliensis, L. mexicana, L. panamensis, and L. guyanensis [15]. Old world species can be found in Asia, the Middle East, the Mediterranean Basin, and Africa, whereas new world species are found in the Americas [16].

4.2 Vector

Approximately, in over all 600 known species of sand flies, 10% act as disease vectors. And only 30 are important from public health point. Particular species of Leishmania are transmitted by particular adult female sand fly of phlebotomine belonging to either Phlebotomus spp. (Old World) or Lutzomyia spp. (New World) to either incriminated or suspected reservoir hosts [17]. The sand flies generally are active at night and inoculate the parasite when they bite humans (“from dusk to dawn”) [18] and are less active in the hottest day-time, but still bite if they are bothered. Sand flies do not make noise, they are small, and their bites might not be noticed the parasite are spread. Adult sand flies often inhabit rock cracks, hollows, and rodent holes, and rest in cool, dark, and humid corners of animal shelters or human dwellings and their ability to acquire, maintain, and transmit the parasites depends on maturity, density, biting habit parasite-vector-host interactions as well as on the ecological and epidemiological features of the infection [19]. Many sand fly species are opportunistic and feed on easy to access animals [20].

4.3 Reservoir hosts (host preference)

Humans, domestic animals, and wild animals are known to act as reservoir hosts such as up to 70 animal species, have been found as natural reservoir hosts of Leishmania parasites.

4.3.1 Human

Despite the human genetic susceptibility, hereditary factors, population ethnicity, genome-wide association, and immunological responses correlated to disease epidemiology [21, 22] the following demographic factors are of consideration.

Age: People of all ages are at risk for leishmaniasis if they live or travel to leishmaniasis endemic areas. Indigenous prevalence increases with age up to 15 years, after which the prevalence stabilizes or decreases, presumably reflecting the progressive buildup of immune protective status [23, 24]. Children under 10 years old displayed the highest proportion (>50%) of new infection [25] potentially due to lack of protective immunity or due to them collecting water or playing in gorges close to sand-fly habitat.

Gender: There is no real gender difference in leishmaniasis, but for decades, male patients have comprised the majority of reported cases, perhaps because of referral bias, more risk-taking behaviors by men or possibly, men are less likely to strictly adhere to recommended preventive measures and thus increase their risk of contracting the disease [26, 27]. The sex-related differences cannot be explained solely in terms of environmental exposure, socio-cultural determinant or healthcare access. Furthermore, transcriptomic evidence is revealing that biological sex is a variable impacting physiology, immune response, drug metabolism, and consequently, the progression of disease [28].

Poverty: Poverty increases the risk for leishmaniasis due to remote and rural inhabitance, low-income, malnutrition, poor waste management (such as open sewerage), poor housing and domestic sanitary conditions which increase sand-fly breeding and resting sites, as well as their access to humans. Sand flies are attracted to crowded housing as these provide a good source of blood-meals. Human behavior, such as sleeping outside or on the ground, may increase risk. Malnutrition and protein deficit, as well as a lack of iron, zinc, and vitamin A in the diet is also a risk factor for complications and for the disease progressing to kala-azar [29].

Population mobility: Migration, tourism, shipment to an area of endemic illness, and occupational exposure of non-immune people into areas with existing transmission cycles increase the risk of infection and epidemics leishmaniasis are often associated with massive migration, internal dislocation, and the population movement [30, 31].

4.3.2 Domestic animals

Dogs are the known reservoirs for the parasites of all types of leishmaniasis and natural host for L. infantum, L. chagasi, L. tropica, and L. peruviana as being infected by them, prevalently in Mediterranean, Asia, and Latin America [32]. Cats are considered secondary reservoirs of the infection in endemic areas as Leishmaniasis has been reported sporadically in several parts of the world [33, 34].

Cattle may possibly increase transmission burden by remaining as untreated reservoir for the parasite, their closeness to human owners, and because of increased availability of blood meals for the sand fly [35].

4.3.3 Wild animals

The detection of Leishmania infection in rodents, suggests that wild animals are also contributing to maintaining the life cycle and transmission of Leishmaniasis. Several rodents, namely, Mus musculus (domestic mouse), Microtus socialis, Rattusrattus (black rat), Cercomys cunicularius (wild rat), Mesocricetus auratus (Syrian hamsters), and marsupial e.g. Didelphis albiventris (opossum) in America, Africa, and Asia lead to spread of leishmaniasis [36, 37]. Other potential reservoirs are squirrels, wild canids, reptiles, and bats [38, 39, 40].

4.4 Ecology/environment

Leishmaniasis is climate-sensitive such as the pathogens, vectors, and hosts involved in the transmission cycle are environmentally sensitive [41] and impacted by climate change and human modification of ecosystems, therefore, changes in ecological settings (range from rain forests to deserts), rainfall, atmospheric temperature, and humidity resulting in fluctuations in sand fly numbers [42] due to variation in the developmental time and metabolism of sand flies and Leishmania development cycle within vector [43]. Humidity and moisture from rainfall or in the soil dealing with survival, development, and activity of sand flies. The matter of hygiene, (which is generally neglected in rural areas), presence of waste or stables in the vicinity of houses, use of traditional building materials for house construction, are all environmental factors that favor the development of the vector and reservoirs, therefore impact the incidence and distribution of leishmaniasis in different regions of the world. Environmental changes such as conversion of natural forest to other land uses, habitat destruction, altered landscape composition, urbanization, human incursion into forested areas, tourism into natural areas, the creation of roadways, energy networks, new farmlands, water management, and poorly planned urban development play an important role in Leishmaniasis epidemiology [44].

Advertisement

5. Transmission of pathogens

Understanding the transmission cycles is very important in effective prevention of leishmaniasis. There is no direct transmission from person to person and the indirect (vector-born) transmission of Leishmania species that cause VL or CL can be zoonotic or anthroponotic [45] depends on the characteristics of the parasite and sand-fly species, characteristics of the transmission sites, current and past exposure of people to the parasite, and human behavior. The zoonotic transmission from canine to humans, is found in the Mediterranean region and many other drier regions of Latin America. Leishmania species reported from dogs and occasionally from cats include L. mexicana, Labrus donovani, and L. braziliensis. Cats are at risk of infection especially in areas where these parasites are endemic [19]. In many endemic areas, infected people are not necessarily maintaining the transmission cycle, but infected animals along with sand flies, maintain the cycle. Only for anthroponotic transmission, infected people are needed to maintain the cycle (human-sand fly-human), parasite transmission being mostly nocturnal and typically seasonal [46].

The incubation period in human is quite variable, generally 1 to 4 months; range is 10 days to 3 years. Visceral leishmaniasis is 3–8 months (range 10 days to 34 months) and of the Cutaneous leishmaniasis is 2 weeks to several months (rarely up to 3 years).

Advertisement

6. Psycho-social impact

Leishmaniasis due to disfigurement and social stigmatization causes or predisposes severe psychological disorders and negatively affects the quality of life varied from minor domestic restrictions to severe physical and emotional isolation that results in poor mental health [47]. The adolescents with lesions are often faced with difficulty in social relations such as finding job, friends, spouse or deemed unsuitable for marriage or social communal life. While the children disfigured by lesions or scars, due to painful treatment, because of exclusion from play with other children are also psychologically affected and emotionally damaged [48].

The social exclusion, discrimination, and psychosocial impacts negatively affect socioeconomic opportunities which showed that depression and anxiety symptoms were higher in patients. Body satisfaction was also impaired in the groups with active CL and healed scars. Culturally, older people were more accustomed to the CL scar, but younger generations had less acceptance of any lifelong stigma and disfigurement on the face [49].

Understanding the psychosocial consequences, economic cost, health importance and the interaction of pathogenic protozoan, sand flies vectors, environmental impact is encouraging prevention, control, and surveillance of Leishmaniasis under a holistic view and integrated approach of human and veterinary medicine, environmental science, and wildlife conservation under the “One Health” approach.

References

  1. 1. Kammona O, Tsanaktsidou E. Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis. International Journal of Pharmaceutics. 2021;605:120761
  2. 2. Valero NNH, Uriarte M. Environmental and socioeconomic risk factors associated with visceral and cutaneous leishmaniasis: A systematic review. Parasitology Research. 2020;119(2):365-384
  3. 3. Speich B, Croll D, Fuerst T, Utzinger J, Keiser J. Effect of sanitation and water treatment on intestinal protozoa infection: A systematic review and meta-analysis. The Lancet Infectious Diseases. 2016;16(1):87-99
  4. 4. Organization WH. Control of Neglected Tropical Diseases: World Health Organization. WHO; 2021
  5. 5. Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392(10151):951-970
  6. 6. Silva B da, Barreira J, M. Beatriz P.P. Oliveira. Natural phytochemicals and probiotics as bioactive ingredients for functional foods: Extraction, biochemistry and protected-delivery technologies. Trends in Food Science & Technology. 2016;50:144-158
  7. 7. Arroub H, Hamdi S, Ajaoud M, Habbari K, Lemrani M. Epidemiologic study and molecular detection of Leishmania and sand fly species responsible of cutaneous leishmaniasis in Foum Jamaa (Azilal, atlas of Morocco). Acta Tropica. 2013;127(1):1-5
  8. 8. El Hamouchi A, Ajaoud M, Arroub H, Charrel R, Lemrani M. Genetic diversity of Leishmania tropica in Morocco: Does the dominance of one haplotype signify its fitness in both predominantly anthropophilic Phlebotomus sergenti and human beings? Transboundary and Emerging Diseases. 2019;66(1):373-380
  9. 9. Pires M, Wright B, Kaye PM, da Conceição V, Churchill RC. The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review. PLoS One. 2019;14(10):e0223313
  10. 10. Rafferty J. Curing the stigma of leprosy. Leprosy Review. 2005;76(2):119-126
  11. 11. Organization WH. Leishmaniasis. Fact Sheet N 375. Updated January 2014. Geneva, Switzerland: World Heal Organ; 2014
  12. 12. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: A review. F1000Research. 2017;6:750
  13. 13. GHO. By category. Leishmaniasis [Internet]. Available from: https://apps.who.int/gho/data/node.main.NTDLEISH?lang=en
  14. 14. Pigott DM, Bhatt S, Golding N, Duda KA, Battle KE, Brady OJ, et al. Global distribution maps of the leishmaniases. eLife. 2014;3:e02851
  15. 15. Kevric I, Cappel MA, Keeling JH. New world and old world Leishmania infections: A practical review. Dermatologic Clinics. 2015;33(3):579-593
  16. 16. Mans DR, Kent AD, Hu R, Schallig H. Epidemiological, biological and clinical aspects of leishmaniasis with special emphasis on Busi Yasi in Suriname. Journal of Clinical & Experimental Dermatology Research. 2017;8(02):388
  17. 17. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Medical and Veterinary Entomology. 2013;27(2):123-147
  18. 18. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366(9496):1561-1577
  19. 19. Ready PD. Biology of phlebotomine sand flies as vectors of disease agents. Annual Review of Entomology. 2013;58:227-250
  20. 20. Abbasi I, Cunio R, Warburg A. Identification of blood meals imbibed by phlebotomine sand flies using cytochrome b PCR and reverse line blotting. Vector-Borne Zoonotic Diseases. 2009;9(1):79-86
  21. 21. Castellucci LC, Almeida L, Cherlin S, Fakiola M, Carvalho E, Figueiredo AB, et al. A Genome-wide association study highlights a regulatory role for IFNG-AS1 contributing to cutaneous leishmaniasis in Brazil. bioRxiv. 2020
  22. 22. Chakravarty J, Hasker E, Kansal S, Singh OP, Malaviya P, Singh AK, et al. Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study. PLoS Neglected Tropical Diseases. 2019;13(3):e0007216
  23. 23. Douba MD, Abbas O, Wali A, Nassany J, Aouf A, Tibbi MS, et al. Chronic cutaneous leishmaniasis, a great mimicker with various clinical presentations: 12 years experience from Aleppo. Journal of the European Academy of Dermatology and Venereology. 2012;26(10):1224-1229
  24. 24. Reithinger R, Dujardin J-C, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. The Lancet Infectious Diseases. 2007;7(9):581-596
  25. 25. van Henten S, Adriaensen W, Fikre H, Akuffo H, Diro E, Hailu A, et al. Cutaneous leishmaniasis due to Leishmania aethiopica. EClinicalMedicine. 2018;6:69-81
  26. 26. Malaria Consortium C. Leishmaniasis control in eastern Africa: Past and present efforts and future needs. Situation and Gap Analysis. 2010:86
  27. 27. Lezama-Davila CM, Oghumu S, Satoskar AR, Isaac-Marquez AP. Sex-associated susceptibility in humans with chiclero’s ulcer: Resistance in females is associated with increased serum-levels of GM-CSF. Scandinavian Journal of Immunology. 2007;65(2):210-211
  28. 28. Lockard RD, Wilson ME, Rodríguez NE. Sex-related differences in immune response and symptomatic manifestations to infection with Leishmania species. Journal of Immunology Research 2019;2019.
  29. 29. Organization WH. Leishmaniasis: Fact Sheet N 375, Updated January 2014. WHO; 2014
  30. 30. Fakhar M, Ghohe HP, Rasooli SA, Karamian M, Mohib AS, Hezarjaribi HZ, et al. Genetic diversity of Leishmania tropica strains isolated from clinical forms of cutaneous leishmaniasis in rural districts of Herat province, Western Afghanistan, based on ITS1-rDNA. Infection, Genetics and Evolution. 2016;41:120-127
  31. 31. Charyyeva A, Çetinkaya Ü, Özkan B, Şahin S, Yaprak N, Şahin I, et al. Genetic diversity of Leishmania tropica: Unexpectedly complex distribution pattern. Acta Tropica. 2021;218:105888
  32. 32. Gramiccia M. Recent advances in leishmaniosis in pet animals: Epidemiology, diagnostics and anti-vectorial prophylaxis. Veterinary Parasitology. 2011;181(1):23-30
  33. 33. Soares CSA, Duarte SC, Sousa SR. What do we know about feline leishmaniosis? Journal of Feline Medicine and Surgery. 2016;18(6):435-442
  34. 34. Longoni SS, López-Cespedes A, Sánchez-Moreno M, Bolio-Gonzalez ME, Sauri-Arceo CH, Rodríguez-Vivas RI, et al. Detection of different Leishmania spp. and Trypanosoma cruzi antibodies in cats from the Yucatan peninsula (Mexico) using an iron superoxide dismutase excreted as antigen. Comparative Immunology, Microbiology and Infectious Diseases. 2012;35(5):469-476
  35. 35. Hirve S, Boelaert M, Matlashewski G, Mondal D, Arana B, Kroeger A, et al. Transmission dynamics of visceral leishmaniasis in the Indian subcontinent–a systematic literature review. PLoS Neglected Tropical Diseases. 2016;10(8):e0004896
  36. 36. Pourmohammadi B, Motazedian MH, Kalantari M. Rodent infection with Leishmania in a new focus of human cutaneous leishmaniasis, in northern Iran. Annals of Tropical Medicine and Parasitology. 2008;102(2):127-133
  37. 37. Lainson R. The American leishmaniases: Some observations on their ecology and epidemiology. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1983;77(5):569-596
  38. 38. Kassahun A, Sadlova J, Benda P, Kostalova T, Warburg A, Hailu A, et al. Natural infection of bats with Leishmania in Ethiopia. Acta Tropica. 2015;150:166-170
  39. 39. Abebe A, Evans DA, Gemetchu T. The isolation of Leishmania aethiopica from the ground squirrel Xerus rutilus. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1990;84(5):691
  40. 40. Gebresilassie A, Yared S, Aklilu E. Sandfly fauna and ecological analysis of Phlebotomus orientalis and Phlebotomus martini in the lowland foci of visceral leishmaniasis in Somali regional state, Southeast Ethiopia. Asian Pacific Journal of Tropical Medicine. 2020;13(1):31
  41. 41. Purse BV, Masante D, Golding N, Pigott D, Day JC, Ibañez-Bernal S, et al. How will climate change pathways and mitigation options alter incidence of vector-borne diseases? A framework for leishmaniasis in south and Meso-America. PLoS One. 2017;12(10):e0183583
  42. 42. Elmazini S, Ejghal R, Bekhti K, Lemrani M. The sporadic cutaneous leishmaniasis due to Leishmania infantum in Morocco: A presumably trend towards endemicity. Acta Tropica. 2021;227:106288
  43. 43. Kholoud K, Denis S, Lahouari B, El Hidan MA, Souad B. Management of leishmaniases in the era of climate change in Morocco. International Journal of Environmental Research and Public Health. 2018;15(7):1542
  44. 44. Semenza JC, Suk JE. Vector-borne diseases and climate change: A European perspective. FEMS Microbiology Letters. 2018;365(2):fnx244
  45. 45. Assefa A. Leishmaniasis in Ethiopia: A systematic review and meta-analysis of prevalence in animals and humans. Heliyon. 2018;4(8):e00723
  46. 46. Alten B, Maia C, Afonso MO, Campino L, Jiménez M, González E, et al. Seasonal dynamics of phlebotomine sand fly species proven vectors of Mediterranean leishmaniasis caused by Leishmania infantum. PLoS Neglected Tropical Diseases. 2016;10(2):e0004458
  47. 47. Hofstraat K, van Brakel WH. Social stigma towards neglected tropical diseases: A systematic review. International Health. 2016;8(Suppl. 1):i53-i70. DOI: 10.1093/inthealth/ihv071
  48. 48. Pal B, Murti K, Siddiqui NA, Das P, Lal CS, Babu R, et al. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis. Health and Quality of Life Outcomes. 2017;15(1):1-7
  49. 49. Chahed MK, Bellali H, Ben Jemaa S, Bellaj T. Psychological and psychosocial consequences of zoonotic cutaneous leishmaniasis among women in Tunisia: Preliminary findings from an exploratory study. PLoS Neglected Tropical Diseases. 2016;10(10):e0005090

Written By

Ghulam Rahim Awab

Submitted: 28 November 2022 Reviewed: 16 February 2023 Published: 22 March 2023